Logo image of RR

RICHTECH ROBOTICS INC-CL B (RR) Stock Fundamental Analysis

NASDAQ:RR - Nasdaq - US7655041058 - Common Stock - Currency: USD

2.58  +0.39 (+17.81%)

After market: 2.2398 -0.34 (-13.19%)

Fundamental Rating

3

Taking everything into account, RR scores 3 out of 10 in our fundamental rating. RR was compared to 128 industry peers in the Machinery industry. RR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. RR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year RR has reported negative net income.
RR had a negative operating cash flow in the past year.
RR Yearly Net Income VS EBIT VS OCF VS FCFRR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -2M -4M -6M -8M -10M

1.2 Ratios

With a Return On Assets value of -17.38%, RR is not doing good in the industry: 82.03% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -17.92%, RR is doing worse than 77.34% of the companies in the same industry.
Industry RankSector Rank
ROA -17.38%
ROE -17.92%
ROIC N/A
ROA(3y)-12.12%
ROA(5y)N/A
ROE(3y)-14.3%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RR Yearly ROA, ROE, ROICRR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -50 -100 -150 -200 -250

1.3 Margins

Looking at the Gross Margin, with a value of 73.90%, RR belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
RR's Gross Margin has improved in the last couple of years.
RR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 73.9%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.85%
GM growth 5YN/A
RR Yearly Profit, Operating, Gross MarginsRR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

6

2. Health

2.1 Basic Checks

RR does not have a ROIC to compare to the WACC, probably because it is not profitable.
RR has more shares outstanding than it did 1 year ago.
RR has a better debt/assets ratio than last year.
RR Yearly Shares OutstandingRR Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M
RR Yearly Total Debt VS Total AssetsRR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

RR has an Altman-Z score of 95.55. This indicates that RR is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 95.55, RR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
RR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
RR has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. RR outperforms 85.94% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 95.55
ROIC/WACCN/A
WACC10.37%
RR Yearly LT Debt VS Equity VS FCFRR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 10M -10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 39.74 indicates that RR has no problem at all paying its short term obligations.
RR has a better Current ratio (39.74) than 100.00% of its industry peers.
RR has a Quick Ratio of 38.33. This indicates that RR is financially healthy and has no problem in meeting its short term obligations.
RR has a better Quick ratio (38.33) than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 39.74
Quick Ratio 38.33
RR Yearly Current Assets VS Current LiabilitesRR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M

More info and screens

4

3. Growth

3.1 Past

RR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -315.57%.
RR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -50.79%.
RR shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.08% yearly.
EPS 1Y (TTM)-315.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.35%
Revenue 1Y (TTM)-50.79%
Revenue growth 3Y-11.08%
Revenue growth 5YN/A
Sales Q2Q%13.65%

3.2 Future

The Earnings Per Share is expected to grow by 18.07% on average over the next years. This is quite good.
RR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 77.92% yearly.
EPS Next Y-32.73%
EPS Next 2Y-3.05%
EPS Next 3Y18.07%
EPS Next 5YN/A
Revenue Next Year76.49%
Revenue Next 2Y107.86%
Revenue Next 3Y77.92%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
RR Yearly Revenue VS EstimatesRR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M 20M
RR Yearly EPS VS EstimatesRR Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -0.05 -0.1 -0.15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

RR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year RR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RR Price Earnings VS Forward Price EarningsRR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RR Per share dataRR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 0.3 0.4

4.3 Compensation for Growth

A more expensive valuation may be justified as RR's earnings are expected to grow with 18.07% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.05%
EPS Next 3Y18.07%

More info and screens

0

5. Dividend

5.1 Amount

RR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RICHTECH ROBOTICS INC-CL B

NASDAQ:RR (5/16/2025, 8:20:15 PM)

After market: 2.2398 -0.34 (-13.19%)

2.58

+0.39 (+17.81%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners7.72%
Inst Owner Change99.15%
Ins Owners3.82%
Ins Owner Change-2.04%
Market Cap287.46M
AnalystsN/A
Price TargetN/A
Short Float %17.2%
Short Ratio1.64
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)24.53%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 65.48
P/FCF N/A
P/OCF N/A
P/B 5.76
P/tB 7.13
EV/EBITDA N/A
EPS(TTM)-0.12
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0.04
BVpS0.45
TBVpS0.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.38%
ROE -17.92%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 73.9%
FCFM N/A
ROA(3y)-12.12%
ROA(5y)N/A
ROE(3y)-14.3%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.85%
GM growth 5YN/A
F-Score4
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 39.74
Quick Ratio 38.33
Altman-Z 95.55
F-Score4
WACC10.37%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-315.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.35%
EPS Next Y-32.73%
EPS Next 2Y-3.05%
EPS Next 3Y18.07%
EPS Next 5YN/A
Revenue 1Y (TTM)-50.79%
Revenue growth 3Y-11.08%
Revenue growth 5YN/A
Sales Q2Q%13.65%
Revenue Next Year76.49%
Revenue Next 2Y107.86%
Revenue Next 3Y77.92%
Revenue Next 5YN/A
EBIT growth 1Y-1029.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-103.87%
EBIT Next 3Y18.53%
EBIT Next 5YN/A
FCF growth 1Y-289.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-111.56%
OCF growth 3YN/A
OCF growth 5YN/A